Michelle McGuinness
Corporate Officer/Principal bij Huntington's Disease Society of America
Profiel
Ms. Michelle McGuinness is VP-Regulatory Affairs & Quality Assurance at Veloxis Pharmaceuticals A/S and a Director-Southeastern Pennsylvania Chapter at Huntington's Disease Society of America.
She received her undergraduate degree from Kean University and a graduate degree from the Temple University School of Pharmacy.
Actieve functies van Michelle McGuinness
| Bedrijven | Functie | Begin |
|---|---|---|
| Huntington's Disease Society of America | Corporate Officer/Principal | - |
Eerdere bekende functies van Michelle McGuinness
| Bedrijven | Functie | Einde |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Algemeen Adviseur | - |
Opleiding van Michelle McGuinness
| Temple University School of Pharmacy | Graduate Degree |
| Kean University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Huntington's Disease Society of America |
